| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 18, 2003
Accepted on December 23, 2003
Department of Pharmacology and Howard Hughes Medical Institute, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390-9050; Departments of Physiology and Internal Medicine, Touchstone Center for Diabetes Research, UT Southwestern Medical Center at Dallas, Dallas, TX 75390-8854; Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892; Current address: Unité de Génétique de la Différenciation, Département de Biologie du Développement, 25/28, Rue du Dr. Roux, Institut Pasteur, 75724 Paris Cedex 15, France
* To whom correspondence should be addressed. E-mail: Davo.Mango{at}utsouthwestern.edu.
In this work, we report the characterization of a novel liver-specific gene (L-UrdPase) whose expression is regulated by a number of hepatic nuclear receptors (including LXRs, PPAR
, FXR, and HNF-4
), which have been shown to be involved in lipid metabolism. L-UrdPase encodes a previously uncharacterized protein with similarity to an intestine-specific uridine phosphorylase. Enzymatic assays confirmed that L-UrdPase has uridine phosphorylase activity. However, L-UrdPase has a highly restricted, non-overlapping pattern of expression with its intestinal counterpart and is regulated in a distinct manner by several different nuclear receptors. The identification of the liver uridine phosphorylase and its characterization as a target of lipid-sensing nuclear receptors implies the existence of a previously unknown nuclear receptor signaling pathway that links lipid and uridine metabolism.
NURSA Molecule Pages Link:
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |